Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 8906151
Calcium phosphate composition and process for producing the same
granted -
US 8906870
MicroRNA (miRNA) for the diagnosis and treatment of heart diseases
granted -
US 8907089
Fused heterocyclic ring derivative and use thereof
granted -
US 8906964
Methods of administering compositions comprising docosapentaenoic acid
granted -
US 2014357564
Von Willebrand Factor Variants Having Improved Factor VIII Binding Affinity
granted -
US 2014356438
PERIPHERALLY ADMINISTERED VISCOUS FORMULATIONS
granted -
US 8900599
Conjugates of Plasmodium falciparum surface proteins as malaria vaccines
granted -
US 8901173
Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
granted -
US 8901117
Small molecule inhibitors of MDM2 and the uses thereof
granted -
US 8900638
Solid preparation comprising alogliptin and metformin hydrochloride
granted -
US 8901309
Fused triazoles for the treatment or prophylaxis of mild cognitive impairment
granted -
US 8901279
Humanized antibodies with anti-tumor activity
granted -
US 8901277
Interferon alpha mutant and its polyethylene glycol derivative
granted -
US 8901276
Peptide reagents and methods for detection of colon dysplasia
granted -
US 8901246
Method for preparing branched functionalized polymers using branched polyol cores
granted -
US 8901199
Compositions and methods for UV-curable cosmetic nail coatings
granted -
US 8901171
Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent
granted -
US 8901169
Neprilysin inhibitors
granted -
US 8901141
Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them
granted -
US 8901095
Selective inhibition of polyglutamine protein expression
granted -
US 8901113
Methods and compositions for deterring abuse
granted -
US 8900818
Recombinant antigen for diagnosis and prevention of murine typhus
granted -
US 8900880
Viral citrullinated peptides and uses thereof
granted -
US 8901093
Custom vectors for treating and preventing pancreatic cancer
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.